By capitalizing on its advantages for business of all sizes, Wisconsin is seeing significant growth in legacy and emerging ...

Eli Lilly, BCE, Suncor, Canada Goose, Bombardier, Thomson Reuters and Lightspeed reported earnings this week. Here are the details for Canadian investors.

Bitcoin has fluctuated within a narrow range in recent sessions, reflecting investor caution in an uncertain macroeconomic ...

Global stocks mostly rose Thursday on easing trade tensions, with London and Frankfurt hitting record highs ahead of key US ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...

Despite heavy demand for its weight-loss and diabetes treatments, limited supply hobbled Eli Lilly's fourth-quarter sales.

At the same time, Bessent's emphasis on expanding energy supply omits other significant inputs for the 10-year. "Concrete ...

Wall Street drifted through mixed trading Thursday as rising fashion and cigarette stocks worked against drops for Ford Motor ...

Surveillance video, license plate readers and social media helped police identify who they say is the second person who fired ...

Bristol-Myers Squibb Co (NYSE:BMY) announced a fourth-quarter earnings and revenue win, but also unveiled a weak 2025 outlook ...

Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations, and issued upbeat 2025 guidance. Fourth-quarter adjusted earnings came in at $5.32 a share, above ...

Eli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.